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Abstract
Objective—Since states’ public health systems differ as to pandemic preparedness, this study
explored whether such heterogeneity among states could affect the nation’s overall influenza rate.
Design—The CDC produced a uniform set of scores on a 100-point scale from its 2008 national
evaluation of state preparedness to distribute materiel from the Strategic National Stockpile (SNS).
This study used these SNS scores to represent each state’s relative preparedness to distribute
influenza vaccine in a timely manner and assumed that “optimal” vaccine distribution would reach
at least 35% of the state’s population within 4 weeks. The scores were used to determine the
timing of vaccine distribution for each state: each 10-point decrement of score below 90 added an
additional delay increment to the distribution time.
Setting and Participants—A large-scale agent-based computational model simulated an
influenza pandemic in the U.S. population. In this synthetic population each individual or agent
had an assigned household, age, workplace or school destination, daily commute, and domestic
inter-city air travel patterns.
Main Outcome Measures—Simulations compared influenza case rates both nationally and at
the state level under three scenarios: no vaccine distribution (baseline), optimal vaccine
distribution in all states, and vaccine distribution time modified according to state-specific SNS
score.
Results—Between optimal and SNS-modified scenarios, attack rates rose not only in low-
scoring states but also in high-scoring states, demonstrating an inter-state spread of infections.
Influenza rates were sensitive to variation of the SNS-modified scenario (delay increments of 1-
day versus 5-days), but the inter-state effect remained.
Conclusions—The effectiveness of a response activity such as vaccine distribution could
benefit from national standards and preparedness funding allocated in part to minimize inter-state
disparities.
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Introduction
U.S. states have a heterogeneous array of public health systems, defined as the
“constellation of individuals and organizations in the public and private sectors that provide
information and assets to promote population health, provide health care delivery, and
prevent disease and injury.” 1 But state-specific models are unique. Each has its own
statutory framework, funding and staffing patterns, and performance requirements.2, 3
Legally, economically, and operationally, state public health systems function independently
of each other and of federal controls 4 despite recent efforts to create national standards. 5, 6
The World Health Organization recommends national-level pandemic influenza planning.7
But in the U.S., the state-based approach to planning produces substantial heterogeneities in
emergency preparedness.8 For example, during the H1N1 pandemic of 2009–2010, there
was wide variation among states in vaccination coverage.9 One study attributed these
differences in part to factors arising from state-level policy and planning decisions,
including time required of vaccinators to order allocated doses, number of vaccine
shipments to vaccinator locations, and existence of school-based and public-access areas for
vaccine distribution.10
Differences in emergency preparedness among states have been a matter of national policy
concern for some time. The 2009 National Health Security Strategy lists “community
interventions for disease control” (such as vaccine distribution) among the criteria for
assessing performance capabilities but also acknowledges that relevant measures for this
capability do not exist in the CDC’s guidance accompanying preparedness funding
grants.11 p.86
Motivated by the need to evaluate how effectively federal preparedness dollars were being
used to improve state-level preparedness, the Centers for Disease Control and Prevention
(CDC) has evaluated each state’s preparedness to distribute materiel from for its Strategic
National Stockpile (SNS).12 SNS is the national reserve of medical supplies,
pharmaceuticals, and other resources to be deployed to states and distributed by them in
response to epidemics and other disasters with public health consequences. CDC gave each
state a SNS score based on numerous criteria including: coordination between health agency
and community partners; receiving, staging, and distributing medical materiel; statutory
support for the rapid dispensing of medications; and the type and frequency of training,
exercising, and evaluation of response plans. Thus, the SNS score provides a metric for
evaluating preparedness based on public health system characteristics with validity and
relevance to the quality of state-specific responses to emergencies such as a novel influenza
pandemic.
CDC did not use SNS scores explicitly for making inter-state comparisons or for evaluating
national preparedness. However, the likelihood that under-preparedness in some states might
affect outcomes in other states presents an important question for planning and policy-
making. This study used SNS scores in an agent-based computational model as a proxy for
state-specific preparedness to explore the potential inter-state and national effects of
heterogeneity among states’ public health systems. The study simulated the emergency
distribution of vaccines to state populations as a pandemic mitigation strategy, with
timeliness scaled to each state’s standardized SNS score. The results offer insights for
national and state-level preparedness plans and policy-making and support the use of
modeling as a tool for policy-relevant research.
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Modeling as a Method for Preparedness Research
There is difficulty inherent in public health preparedness research. Public health systems are
complex, 13 and public health emergencies like pandemics are infrequent and locally
heterogeneous. Previously published studies based on expert panel methods and table-top
exercises have contributed insights for policy makers14, 15 but have lacked empirical
validation. Empirical evidence is sparse, since security concerns tend to inhibit the
publication of emergency after-action reports. Case-controlled and randomized trials
comparing disaster outcomes among localities are impractical and ethically problematic.
Large-scale computational modeling provides a novel research tool for public health systems
and preparedness by facilitating inquiry into complex and dynamic problems that are not
amenable to other methods. Agent-based models are, in effect, artificial societies in which
every individual is represented as a distinct computational agent whose activities (e.g., going
to work or school) and whose contacts with other agents are explicitly represented as events
unfold both spatially and chronologically.16 Modeling approaches are already acknowledged
as useful to preparedness researchers and policy makers 17 and have strong credentials in the
study of infectious disease control.18 Such models have simulated the spread of disease
through populations in considerable biomedical and demographic detail, for example, by
representing such disease characteristics as a pathogen’s transmissibility and mortality and
such population characteristics as age, residential density, commuting patterns, contact
frequency, and immunologic status.19 Previously published simulations of influenza
epidemics account for disease and population variations, model their stochastic (randomly
occurring) interactions, and suggest how strategies such as mass vaccination or targeted
vaccination strategies might affect a pandemic.20–23 Previous simulation studies have
experimented with the mitigating effects of antiviral distributions,24 vaccination
programs,20, 22, 25 and school closures.26
SNS Scores as Proxy for State-Specific Preparedness
Computational modeling requires that the relationships between sets of inputs and outputs—
that is, how variations of one might affect the others—be defined in mathematical or
quantitative terms. This study explored the effect of variations in states’ levels of
preparedness by linking the SNS scores to calibrated delays in emergency vaccine
distribution and by comparing how the delays would affect influenza infection rates within
and among states. To date, there exists no experience-based evidence for a quantitative,
scaled correlation between a state’s SNS score and its performance in a distribution of SNS
resources. Nevertheless, as a proxy for state-specific preparedness, the SNS scoring system
is logically compelling. Starting in 2002, each state’s allocation of federal preparedness
funds carried an obligation to prepare for emergency distributions of SNS materiel. The
CDC’s evaluation of state preparedness in 2007 included criteria for legal authorities,
economic and human resources, and operational plans and exercises relevant to
implementation of the SNS program.12 The resulting score for each state represents a
composite indicator of its preparedness that is comparable to that of other states.
Methods
This study uses a pandemic model of the U.S. population with the assumptions that the
population has had no previous exposure and thus no immunity, there is an available
vaccine, and each state’s SNS score has a scaled relationship to the timing of vaccine
distribution. We explored three fictional pandemic scenarios: 1) no vaccine distribution in
any state; 2) 35% vaccination coverage achieved in all 48 contiguous states within four
weeks of the start of the U.S. pandemic; and 3) vaccine distributions in each state scaled to
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its SNS score. This study did not involve the use of human subjects or of any data collected
from human subjects or patient records.
This modeling experiment is fictional, designed to explore the question of how state-specific
preparedness might affect disease rates in the nation as a whole during an influenza
pandemic. While the model’s specifications are grounded in data from actual population and
influenza characteristics, this study is intended neither to represent any historical influenza
outbreak nor to forecast the outcome of any possible future outbreak. Rather, it tests the
hypothesis that total U.S. influenza attack rate (% of the population infected) in a pandemic
is sensitive to variations among states in their preparedness to distribute vaccines.
Large-Scale Pandemic Model of U.S. Population
This study used a national large-scale agent-based computer model that has been described
previously as simulating epidemics and epidemic control interventions.19 The model has
293,532,887 computer-coded “agents” with Census-based age and household distributions to
represent the resident population of the 48 contiguous states and the District of Columbia of
approximately 2006. The synthetic population is based on high-resolution LandScan data, 27
and each agent is assigned to a household to represent realistic age and population
distributions using Census and household distribution data.28 Agents have assigned
workplaces or schools, to which they travel to on a daily basis. Workplaces are assigned to
agents based on a kernel derived from the STP64 data set for commuting distances,29 and
school assignments are made from a geocoded database of US schools.30 Domestic airline
travel is also included and parameterized with the Origin-Destination Survey of Airline
Passenger Traffic dataset for airport activity. 31
Each simulated day, each agent can assume one of four possible states: susceptible, exposed,
infectious, and recovered (or immune). All agents begin in the susceptible state, i.e., able to
be infected by the influenza virus. The pandemic begins when infectious agents are
introduced into the population. Influenza spreads through the population as infectious agents
come in contact with susceptible agents in their social network. The basic reproduction
number, R0, is the average number of new cases that each infectious individual would
produce in a completely susceptible population. A susceptible agent becomes infected with a
probability that depends not only on the inherent transmissibility of the virus but also on the
intensity and frequency of contact with infectious agents; and contacts depend on the agent
and its location. Published studies detail the calibration of the model, which is based on data
from previous epidemics: 30% of infections occur in the household, 37% in the school or
workplace, and 33% in the community, consistent with values used by others to reproduce
other influenza pandemics.19 Community contacts depend on a “gravity model” that scales
down the likelihood of transmission as the physical distance increases between two agents.
Transmission of influenza is modeled through contact of individuals at these various
locations.
Once infected, the agent enters an exposed state, during which it cannot transmit the virus to
others. The agent remains in the exposed state for the duration of the incubation period
(Weibull distribution with 1.48 mean ± 0.47 days) and then transitions to the infectious
state, when transmission of the virus to others can occur. Agents in the infectious state have
a probability of being symptomatic (that is, exhibiting clinical symptoms) or asymptomatic.
Asymptomatic individuals shed less virus and are therefore 50% as infectious as
symptomatic individuals. The agent remains in the infectious state for 7 days and then
transitions to the recovered state, remaining immune to the virus for the remainder of the
simulation.
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To simulate the start of a U.S. epidemic, the model assumes the importation of a novel virus
from an international source. An equation-based SEIR compartment model of the global
population with an R0 of 1.6 generates the number of newly infectious agents that enter (i.e.,
travel into) the U.S. each pandemic day. These new imports are randomly spread throughout
the U.S. population.
As with all individual based disease transmission models, this simulation is stochastic—
meaning that simulation runs with the same set of initial conditions are probabilistic and do
not produce exactly similar epidemics. Based on previous experiments with averaging up to
100 simulation runs, we found that averaging 10 runs produced statistically similar results
that adequately account for this stochasticity. The model requires supercomputing resources,
and these simulations were performed at the Pittsburgh Supercomputing Center.
Vaccine Distribution
We assumed that vaccinating at least 35% of a population within a four-week period would
constitute “optimal” vaccine distribution. This approximate target is based on the calculation
of critical vaccination coverage in which pcrit,, is the fraction of the population that one
needs to vaccinate in order to avoid a major outbreak. Mathematical compartment models
(which assume homogenous mixing) have previously established that pcrit,= 1-1/R0. So, for
a R0=1.5 epidemic in a homogenously mixing population, pcrit would equal 33%, a
threshold that needs to be achieved prior to the peak of the epidemic. In our simulation runs,
this threshold is achieved within 4 weeks of the start of the epidemic, prior to the peak. This
assumption of 35% as optimal vaccine distribution is an approximation, since this pandemic
model has heterogeneous mixing of the population, the actual pcrit, may differ.
At the beginning of each simulation run that implements vaccination, a randomly selected
50% of each state’s population enters a vaccination queue, and agents younger than 24 years
move to the front of the queue. Agents who become infectious and symptomatic before
receiving a vaccine are removed from the queue. The vaccines available on a given day are
distributed to individuals in the queue until no vaccines or no individuals in queue remain.
The vaccine has a 70% protective efficacy, meaning that, vaccinated agents have a 70%
probability of transitioning to the recovered state, after the 7-day lag time between vaccine
administration and achieving protection.
There has been no activation of the SNS system for an emergency vaccine distribution to
supply empirical evidence for scaling the SNS scores to actual performance. During the
H1N1 pandemic of 2009, vaccine distributions used routine public and private clinical
channels;32 however, CDC noted that state-specific vaccination coverage rates varied
considerably and attributed these variations to intra-state “program factors.”9 Anecdotal
evidence suggests that differences in public health system capacity can affect vaccine
availability: among counties in one state where some had local health departments and
others had none, H1N1 vaccine distribution times varied up to 35 days.33
For this study, the state-specific SNS scores were scaled to the timing of vaccine distribution
and coded into the model, yielding results in terms of case incidence at the national, intra-
state, and inter-state levels. The SNS scores for 47 states and the District of Columbia were
based on a 100-point scale12 with a range of 24 to 97, a mean of 79, and a median of 85; the
median was used as the score for the one missing state. The model assumed that any state
with a SNS score of 90 to 100 would achieve “optimal” vaccine distribution under the SNS-
modified scenario. For other states, the timing of vaccine distribution was delayed
incrementally for every 10-point decrement of SNS score. Because of the obvious sensitivity
of results to this calibration, we conducted simulations at both a low-end (1-day) delay
increment and a high-end (5-days) delay increment. Under these assumptions, the maximum
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delay beyond optimal in any state was 6 days for the low-end increment and 30 days for the
high-end increment.
Results
Table 1 presents the overall results of simulations under each scenario and illustrates the
model’s considerable sensitivity to the state-specific variations in timing of vaccine
distribution. Nationally, the overall attack rate of influenza in the population fell from 44%
with no vaccine distribution to 13% with optimal vaccine distribution; and SNS-modified
vaccine distribution produced attack rate of 15% assuming only 1-day delay increments per
10-point decrement in SNS score and 28% assuming 5-day delay increments. Peak incidence
was 5.5 million cases without vaccination, 1.3 million cases with optimal vaccination, and
1.59 million and 3.4 million cases, respectively, under the 1-day and 5-day delay increment
SNS-modified scenarios. The peak day was only slightly different under each scenario, an
effect attributable to the initiation of vaccine distribution no earlier than day 88 of the U.S.
pandemic even in the optimal scenario.
Figure 1 shows the national results in terms of cumulative case incidence over the course of
the pandemic for each of the four scenarios: no vaccine distribution resulted in 128 million
cases; optimal vaccine distribution resulted in 38 million cases; SNS-modified vaccine
distribution with 1-day delay increments resulted in 44 million cases; and SNS-modified
vaccine distribution with 5-day delay increments resulted in 82 million cases.
Figure 2 shows how the SNS-modified vaccine distribution in low-scoring states affected
not only intra-state rates of incident infection but also inter-state rates. Here the states and
the District of Columbia are grouped by SNS scores in thirds: 17 top-scoring with scores at
90 or above; 17 middle-scoring with scores of 77 to 89; and the 17 low-scoring below 77.
Each group’s average percent-difference in incident cases between optimal and SNS-
modified scenarios is shown as a separate bar; and the two sets of bars show the 1-day and
5-day delay increment scenarios. Under the 1-day incremental delay SNS-modified scenario,
incident cases increased over optimal by 1.67% in the high-scoring group, 2.09% in the
middle-scoring group, and 4.29% in the low-scoring group. Under the 5-day incremental
delay SNS-modified scenario, incident cases increased over optimal by 11.3% in the top-
scoring group, by 17.5% in the middle-scoring group, and by 25.4% in the bottom-scoring
group. Notably, the interstate effect is evident in the top-scoring group, in which all states
had SNS scores of 90 or higher and therefore did not have any delay beyond optimal in
vaccine distribution under the SNS-modified scenario. This group had a higher case
incidence under both SNS-modified scenarios, indicating that infection was transmitted from
the other states where vaccine distributions were delayed.
Discussion and Limitations
Using the SNS scores to calibrate a pandemic simulation, this large-scale agent-based model
shows how delayed vaccine distributions nationally can result in higher peak case numbers
and higher rates of incidence; and it shows how greater delays in some states result in higher
peak cases and incidence rates even in states where no incremental delays occur. This
approach does not require a literal or actual relationship between SNS score and vaccine-
distribution time. Rather, the score provides a calibrated proxy for state-specific differences
in preparedness. The model’s sensitivity to these state-specific differences underscores the
importance of state-specific measures of public health system preparedness, and its
demonstration of an inter-state effect suggests the need for national standards of
preparedness.
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State-specific measures of public health preparedness are important for state-level policy
making and resource allocation, and the continued development and use of nationally
standardized preparedness metrics like the SNS score are necessary to that purpose.
However, as this modeling experiment shows, national standards such as for vaccine
distribution policies and practices could improve outcomes for the nation as a whole. If
influenza incidence rates among states are in fact interdependent, then the nation’s pandemic
preparedness effort should strive to minimize inter-state disparities.
To date, federal officials have shown reluctance to impose uniform standards on states. The
National Health Security Strategy of 2009 states that “Primary authority for health security
lies with local, state, territorial, and tribal governments.” 11 p.19 This principle influences
how CDC allocates preparedness funding among states, by using guaranteed state
minimums and per-capita rates rather than need assessments or evaluation results.34
Nevertheless, even conservative policy analysts argue in favor of shifting the balance of
authority toward national uniformity of standards when deference to states’ sovereignty
might diminish the overall effectiveness of response. 35 p. 80
The CDC has now conducted and published results from two rounds of SNS-related
evaluation and scoring, the first in 200812 and another in 2010.36 These standardized
evaluations can provide the base of evidence needed to inform performance benchmarks and
guidance. The continued preparedness funding to states could provide a vehicle for setting
performance benchmarks and for targeting extra funds to states where greatest
improvements are needed.
There are three aspects of this study that limit the interpretation of its results. First, interstate
travel and cross-border commuting patterns programmed into the model give rise to the
observed interstate effect, in which disease transmission occurs between and among states.
However, the state-level resolution of results lacks sufficient detail to show which cities or
metropolitan areas might be serving as hubs for disease transmission between states. Further
exploration of the inter-state effect would require county-level or metropolitan-level
calibration of the vaccine distribution simulations for which standardized data are not
currently published.
Second, this model simplifies reality—as do all models, omitting some possibly relevant
details in order to explore how selected factors might affect results. Models of the kind used
in this study do not purport to predict the course of a pandemic, dependent as that would be
on innumerable excluded factors such as individual and social behavioral patterns.
Third, the SNS scores used here as proxy measures of states’ relative preparedness are based
on evaluation of plans rather than actual capabilities; further, inter-rater reliability for CDC’s
scoring process was not reported.12, App. 5,p156–157 Nevertheless, these issues are tangential
to the modeling results, which show that even small delays in the distribution of vaccines
can affect disease outcomes at both state and national levels.
Conclusions
The value of large-scale agent-based modeling is its utility for testing assumptions under
varying conditions that cannot be observed or tested empirically. In this way, modeling
offers a tool for those who must make resource-allocation policies and real-time emergency
decisions in the absence of complete empirical evidence.
In this study, a modeling experiment isolates preparedness as measured by the SNS score
from other factors to assess whether the wide variability of preparedness among states can
affect the national outcome. The fact that states performed quite disparately in distributing
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H1N1 vaccines during the 2009–2010 pandemic substantiates this approach. The results
suggest that investing a portion of federal preparedness funding to raise the capabilities of
the lowest-scoring states would benefit the nation as a whole and would improve outcomes
even among higher-scoring states.
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Figure 1.
Cumulative Cases per Day of Simulated US Influenza Pandemic under Four Vaccine-
Distribution Scenario
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Figure 2.
Comparison of %-change in influenza attack rates from optimal scenario to SNS-modified
scenario among states grouped by SNS score
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Table 1
Data Summary for Simulated 242-Day Pandemic in 48 U.S. States and the District of Columbia under Four
Vaccine-Distribution Scenarios
Vaccine Distribution Scenario
None Optimal SNS-Modified (1-day delayincrement)
SNS-Modified (5-day delay
increment)
Cumulative cases, total 128,133,553 38,041,211 44,436,147 81,855,808
Attack rate 44% 13% 15% 28%
Peak day 128 123 124 126
Incident cases at peak day 5,521,270 1,314,600 1,594,670 3,428,790
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